US Stock MarketDetailed Quotes

XTLB XTL Biopharmaceuticals

Watchlist

2.070
-0.030-1.43%

Close Dec 27 16:00 ET

2.070
0.0000.00%

Post 20:01 ET

11.28MMarket Cap-66.77P/E (TTM)

XTL Biopharmaceuticals Stock Forum

Stock_Drift

Oct 28 04:33

Pre Market Ticks. 5:32am 10/28

$Jet.AI (JTAI.US)$ $ProShares UltraShort Bloomberg Crude Oil ETF (SCO.US)$ $Phunware (PHUN.US)$ $ImmunityBio (IBRX.US)$ $Longeveron (LGVN.US)$ $BIOSIG TECHNOLOGIES INC (BSGM.US)$ $Tarsus Pharmaceuticals (TARS.US)$ $XTL Biopharmaceuticals (XTLB.US)$ $LENZ Therapeutics (LENZ.US)$ $TC BioPharm (TCBP.US)$ $Top Wealth Group Holding (TWG.US)$ $Healthcare Triangle (HCTI.US)$ $Pixie Dust Technologies(Delisted) (PXDT.US)$
📊⚡️📊

Trytosaveabit

Oct 28 03:51

$XTL Biopharmaceuticals (XTLB.US)$ 🤔

Trytosaveabit

Jun 5 08:25

Update

$XTL Biopharmaceuticals (XTLB.US)$ XTL Biopharmaceuticals Enters Agreement To Acquire AI Web Data Company The Social Proxy; Secures $1.5M In Private Placement. XTL Biopharmaceuticals Will Issue ADSs Representing 44.6% of Issued and Outstanding Shr Cap to Hldrs of Social Proxy

Deutsche Trader

Mar 25 09:18

$XTL Biopharmaceuticals (XTLB.US)$ closing out on this one, holding $Altamira Therapeutics (CYTO.US)$ all week for the squeeze. some sources im seeing say CYTO only has a 325k float since the RS last december. makes it very easy to manipulate, but can also easily 10x

Stock Region

Mar 21 14:08

Healthcare Company's Stock Spikes In Volume: Announces Acquisition & Expansion To AI Web Data

XTL Biopharmaceuticals Leverages AI in Healthcare with The Social Proxy Acquisition.
In an unexpected yet strategic move, XTL Biopharmaceuticals Ltd (NASDAQ: XTLB) announced its acquisition of The Social Proxy, a decision that has sent ripples through both the biopharmaceutical and tech industries. This acquisition not only marks XTL's ambitious expansion into the AI and web data sphere but also signific...